AlphaFold predicted structure
SLC6A6 · P31641

Mean pLDDT
86.8/ 100
Confident
620 residues
Confidence breakdown
- Very high(≥ 90)71%
- Confident(70–90)14%
- Low(50–70)8%
- Very low(< 50)8%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
solute carrier family 6 member 6
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Retinal disorders
BIALLELIC, autosomal or pseudoautosomalDilated and arrhythmogenic cardiomyopathy
BIALLELIC, autosomal or pseudoautosomalhypotaurinemic retinal degeneration and cardiomyopathy
cardiomyopathy
retinal degeneration
Retinal dystrophy
revision of total joint arthroplasty
aseptic loosening
uveal melanoma
secondary malignant neoplasm
retinitis pigmentosa
Progressive cone dystrophy
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Sodium- and chloride-dependent taurine transporter
Mediates sodium- and chloride-dependent transport of taurine, a key amino acid (PubMed:31345061, PubMed:31903486, PubMed:39837997, PubMed:40108165, PubMed:40108449, PubMed:40615403, PubMed:40789850, PubMed:41269860, PubMed:41652173, PubMed:8010975, PubMed:8382624, PubMed:8654117). Taurine acts as an anti-aging agent by reducing cellular senescence and combating oxidative stress: levels decline with age and supplementation has been shown to extend lifespan (By similarity). In addition to mediate extracellular taurine uptake, also able to mediate transport of taurine into mitochondria, sustaining mitochondrial translation (PubMed:41652173). Can also mediate transport of beta-alanine, hypotaurine and gamma-aminobutyric acid (GABA) (PubMed:39837997, PubMed:40108165, PubMed:40789850, PubMed:41269860, PubMed:8010975)
SLC6A6 · P31641

Mean pLDDT
86.8/ 100
Confident
620 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0